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In the skin of atopic dermatitis patients, the amount 
of ceramides in the stratum corneum is decreased. 
Although the cause of this decrease tnay be due to the 
higher activity of acylase, a decrease in the activity of 
sphingolipid activator proteins may also be the cause. 
A polyclonal antibody to saposin D, elicited by im-
munizing rabbits with the synthetic polypeptide from 
eDNA of saposin D, cross-reacted with a single 65-
kDa epidermal protein of pi 5.6 in a 2-dimensional 
immunoblot study, suggesting that it was prosaposin, 
the precursor protein of saposin D, from its molecu-
lar weight and demonstrating its immunohistochem-
ical localization in the innermost cell layers of the 
stratutn corneum of the skin. The antigenic material 
was also observed in the epithelium of the esophagus, 
pneutnocytes of the lungs, hepatocytes, and glandu-
lar cells of the stomach. lm1nunoelectron 1nicroscopy 
T he intercellular space of the stratum corneun1 , the cpid erma I barrier, is packed with lamell ar sheets of lipids; 50')1,, of w hich arc ceramides, 25% of which are free cholesterol, and th e rest arc cholesterol sulfate, free fatty acid, and others (Wertz e/ nl, 1985; Rana-
singhe et nl, 1986) . T hese lipids form a barrier against the perme-
ation of water-soluble materials fi·om inside or outside and prevent 
the stratum corneum from becoming dry (Elias ct nl, 1975; Wertz 
and Downing, 1982). T hree pathways have been suggested in the 
synthesis of ceramides in the skin: (i) ce ramidcs are produced by 
degradation of glucosyl-ceramides with ,13-glu cocerebrosidase 
(GCasc; Holleran el nl, 1992, 1993 ), (ii) ccramides are converted 
fi-om sphingomyelin by sphingomyelinase (SM.ase; Menon el nl, 
1986; Yamamura and Tezuka, 1990), and (iii) ceramid es are from 
ric 1/o/Jo synthesis through 3- ketodehydrosphingosinc formed by 
conjugation ofL-serine and paJmitoyl-CoA (Holleran er nl, 1991a, 
1991b). In the nonlesional skin of atopic dermatitis (AD) patients 
(atopic skin), the amount of ceramides extracted fi·om the surface of 
the skin with acetone-ether is signjficantly decreased (lmokawa e/ 
nl, 1991) . The ca use of this decrease may be either the suppression 
of synthesis of cera mides or the enhancement of degradation of 
ceramides. T he enzymatic synthesis and degradation of ceramides 
[GCase and ceramidase (CDase), respectively] were normal in the 
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showed the antigenic material in the cytoplasm of the 
granular cells and the intercellular spaces, either 
between the stratum granulosum and the stratum 
corneum or on the stratum corneum cell envelope. 
By ELISA, the amount of the 65-kDa protein in the 
inner surface skin of the upper arm of atopic derma-
titis patients (nonlesional skin) [4.1 ± 2.0 1-tg per 7 
mm
2 (mean ± SD), n = 10) was found to be signifi-
cantly decreased (p < 0.05) to 66% of that in the 
normal control (6.2 ± 1.5 1-tg per 7 mm2 , n = 10). 
Therefore, the suppression of prosaposin synthesis 
11.1ay be related to the abnormal stratum corneum 
formation in atopic skin through lower activation of 
glucosylcerebrosidase or sphingomyelinase. Key 
wovds: spingolipid activatov pt'Oleius/cet'amides!dt')l ski11/ 
atopic demwtitis.] ll111est Demtatol 109:319-323, 1997 
les ional skin of AD Gin e/ nl, 1994), but the abnormal catabolic 
pathway of sphingomyelin was enhan ced in atopic lesiona.l skin 
(Murata c/ nl, 1996), the activity of an acylase being substantially 
highe r in the lesional skin of AD patients. T he activity of this 
abnormal acylase, however, was high er in pankeratotic lesional 
skin, in which few lameUar granules were formed. SMase and acid 
phosphatase, but not acylase, were rich in the lamellar granule-rich 
fraction obtained fi·om the feta l rat epidermis (Freinkel et nl, 1985). 
Therefore, the lugher activity of acylase in the AD lesiona1 skin may 
not be derived from the enzymes in the lamellar granules but from 
the large lysosomes abnormally fonn ed in keratinocytes in lesional 
skin (Prose el nl, 1965). 
On the other hand, there are five sphingolipid activator proteins 
(SAPs), which are sma U nonenzymatic glycoproteins stimulating 
the lysosomal degradation of vari ous sphingolipids (Furst cl nl, 
1992). SAP-Band SAP-Care essential for the i11 vivo degradation of 
sulfatides by arylsulfatase A and glucosylceramide by glucosylcer-
amide ,13-glucosidase, respectively. Though SAP-D fi·om Gaucher's 
disease spleen is an activator of SMase (Morimoto et n/, 1988), it 
stimulates i11 11i11o the lysosomal degradation of ceramides in skin 
fibrob lasts (Klein et nl, 1994). 
Herein, the localization of prosaposin in nonnal epidermis and its 
amount in atopic skjn were examined by immunohistochemistry, 
inu11unoelcctron microscopy. and enzyme-linked immunosorbent 
assay (ELISA) by using antibody to saposin D. 
MATERIALS AND METHODS 
Polycloual Antibody Production Po lypeptides were synthesized with 
a peptide synthesizer (Shimadzu, Kyoto, Japan) acco rding to the ;nnino acid 
sequences determined from the cON As of saposin D (Morimoto ct nl, 1988; 
Hiraiwa t! l n/, :1993) and human acid SMase (Qu.intcm et n/, 1989; O'Brien 
e l nl. 1991). The synthetic polypeptides were TKQEILAALEKG, identica l to 
amino ac ids 24 -35 in the amino acid sequence of the human saposin D 
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(res idues '129 -440 of prosaposin) and GELQAAEDRGDK, iden tica l to 
;unino acids 408-419 in the amino acid seq uence o f human acid SMase. To 
immunize rabbits w ith com plete Freund 's adjuvan t, 0.6 mg of these 
synthetic po lypep tides bound to ke yhole li mpet hemocyanin (Calbiochem-
Nova biochern, La J o ll a, CA) was used. Two weeks afte r the ini tia l 
iJnnHmi zation. booster injec tions \¥C rc repeated every wcl.!k until a high 
titer of antibody that cross-reacted with the epidermis was o bta ined. 
ELISA To deccnnine w hether or not the 'mtibody reacts with the 
immunized synthe tic po lypeptide itse lf. ELI SA was perfo rmed by the 
technique of Vo ller e/ nl (1978). 
Inununoblot Examination Dcf.,tted skin obta ined with a punch bio psy 
was immed iate ly lyophili zed, minced , homogenized in 50 mM T ris(h)'-
droxymethyl)amim)rnethaue (Tris) hydrochloride buffer , pH 7 .2, contain-
ing I 'X. sodium dodecyl su lfate (SDS; T ris-SDS) in a conica l glass homog-
eni ze r (Tris-SDS extract), and cen trifuged at 15,000 X s fo r 30 min. T he 
15,000 X g supernatant fi·ac tio n was subj ected to SDS-po lyacrylamide ge l 
electrophores is (SDS- PAGE) . transferred to lm mobilon (Mill ipore, Bed-
fo rd, MA) , and allowed to react w ith an ti-saposin D an tiseru m d ilu ted 
I : I 000. For 2-d imensional im m unoblot analysis, the epide rmis o bta ined 
fro m suction b listers was homogenized in 50 mM Tris-H CI bu frer, pH 9.2, 
conta ining 10M urea, S'X. 2-mercaptoethan o l, and S'Y,, Nonidct P-40 (T UM 
buffer) . The 15,000 X .~ supe rnatant fraction was next subjected to 
isoclectric focusing (p i 3 .5-1 0.0) in a capillary tube and then analyzed by 
SDS-PAGE with a 12.5% ge l. After electrophores is, proteins were blotted 
onto Imm obi lon and all owed to react with anti-sapos in D anti body d iluted 
I : 1000. 
Jnununohistoche1nistry T he labeled strept-avidin biotin method 
(LSAll method; Guesdon cl nl, 197'J) was used to detect the localization of 
the an tigen in the cpidcn11 is and other tissues. fo nr- nlicro n1 c ter-thick 
lrozen sections fixed in 95% ethano l at - 20°C for ·1 0 min were incuba ted 
with antiserum di luted ·1: I 000 (anti-sapos in D antibody) or 1 :2000 (anti-
SMase antibody) at :l7°C fo r 30 m in . 
[Jnn1unoclcctron Microscopy Norn1a l lnun an fo rca nn skin o bta in ed 
fro 111 a surgica l operation for a benign skin tumor W<IS minced in to 1-mm 
cubes and immediate ly fi xed in 2.5% g lu ta raldehyde an d 4% parafo rmaldc-
hydc in 50 mM phosphate buffer, pH 7.2, at 4°C fo r 1 h , then ri nsed 
tho roughly in 50 mM phosphate bufrc r, pl-1 7.2 , and embedded in U nicryl 
K4M res in afte r de hydration. T he ul trathin sections were incu bated w ith the 
an ti-sapos in D an tibody (di lu ted I :5000) fo r 15 h ;It 4°C, and then, after 
being rinsed . they were further incubated with an ti-rabbi t lgG goat lgG 
labeled with '15-nm gold 'particles (d ilu ted 1 :100) at 37°C for 30 mi n. 
Finall y, after bei ng sta ined with uranyl acetate and lead ni trate, these 
ultrath in sections were observed un der a 1-! U-7100 electron microscope 
(Hi tachi, Tokyo, Japan). 
The Amount of Prosaposin in Atopk Skin of AD Patients T he 
diagnosis of AD was made accord ing to the cri teri a of Hani fi n and R aj ika 
(1 ')80) . Pun ch-biopsied skin 3 mm in diameter was o bta ined from the inner 
surf.1ce skin (non les iona l skin) of the upper ann of both AD patien ts and 
age-matched nonna l controls. T he specimens were .immediately frozen in 
liquid njtrogcn, I)'Ophil ized , and stored "t - 80°C un til usc. Coment was 
o btai ned befo re biopsy. 
Th~ amount of both the 65-kD<l epidermal protein cross-reac ting with 
anti-saposin D antibody and the 58-kDa epidermal p rote in cross-reacting 
with an ti-SM ,!Se an tibody were estimated by a previo usly repo rted method 
(Scguchi 1'1 nl , 1996) . BricAy, the lyop hiLi zed ski n was m inced and homog-
enized in 50 mM Tris-HC I buffe r, pH 7. 2, con ta ining 1% SDS in a conica l 
glass homogenizer <md centrifuged at 1 5,000 X .~ fo r 1 0 min . An aliquo t of 
the supernatan t fraction was subj ected to SDS-PAGE. bl o tted onto lntmo-
bilon, and allowed to react with e ithe r anti-saposin D an tibody (dilu ted 
I : I 000) or anti-SMase antibody (di luted I : I 000). 
The reaction product was fu rther all owed to react with anti-rabbi t IgG 
goat lgG labeled with peroxidase (d ilu ted ·1 :1 000), and the density of the 
specific protein band of e ithe r 65-kDa or 58- kJ)a was measured. T he 
arno unts of the 65-kDa and 58-kDa proteins we re estim ated fi·o m a sta11 dard 
curve of density l'asus protein concentration produced by using cystatin A 
as a substitute tor prosaposin o r ep ide rmal SMase. beca use the p urifi ed 
tll ate rial was not commerc ia ll y avai lable. An aliquot of cys tatin A (0 .1. -Q .(, 
p.g) was subjected to SDS-PAGE, b lotted on to lmmobilon, and allowed to 
react with an an ti-cys tatin A antibody (d ilu ted 1:1 000). Afte r pe roxidase 
was visua li zed with hydrogen peroxide and diamin obenzidine, its density 
was determined by using a chromatoscanning meter with a sli t o f 1 0 mm X 
0. 5 mm. 
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Figure 1. T he a nti-saposin D antibody binds to a 65-kDa protein 
fr01n the skin. T he homogenate of normal skin w as separated by 
SDS-PAGE, transferred to an lrn mo bil on membrane, and reacted with 
either an ti-saposin D antibody (lnllt' 2) or pre-immune serum (ln11c 3). T he 
extracted prote ins fro m the skin were sta ined with Coomassie brill ian t blue 
R (ln11 e !). Lane M shows rn o lccular marke rs. T he -> indica tes a 65-kDa 
protein. 
R ES ULTS 
Polyclonal Antibodies React with the Immunizing Antigen 
T he t w o p o lycl o n al antibodies r eac te d wi th the resp ective syn th e ti c 
p o lyp e p tides (d a ta n o t sh o wn) . 
A Single 65-kDa Prosaposin-Like Protein Is Present in 
Human Epidermis S D S-PAGE o f th e 1 5 ,00 0 X g supe rna tant 
fra c ti o n o f th e T ri s- SD S ex trac t o f the p unch bio p sie d ski n fro m 
e ith e r a topic skin of AD patie nts or the normal control , blotted 
o n to Jmmo bilo n , ;md in cubate d w ith an ti-sap osin D antibody, g ave 
a sing le (,5- kDa band (Fig 1, indicate d b y ar row) . W h en 5- o r 
1 0- fo ld am o unt o f th e e 'pidermal ex tract was applie d fo r immun o-
bl o t an a lys is. n o 1 0-kDa protein ide nti cal to saposin D was 
d e tec te d. 
T w o -dime n sional e lectroph o resis of th e 1 5,000 X g supe rna tant 
fi·a c tio n o bta in ed from e pide rmis re v eal e d a sin g le 65- kDa immu-
n o reacti ve sp o t a t p i 5.6 (Fig 2) . 
Prosa posin- Like Protein Locates in the Transition Zone of 
Granular Corneocytes lmmunore ac tio n p1·odu cts were ob-
served at th e g ranular-corneocyte transit io n zon e and in t h e inn e r 
ce ll laye rs o f th e stratum corn e um (Fig 3a) , and sp o tty reactio n 
pro du cts were fo und in the stratum corn e um o f the uppe r part of 
acrosyrin g ium and th e h ail' can al in the skin secti o n in c uba te d with 
the an ti- sap osin D antibo d y (Fig 3b,c, indicate d b y---"). In co n tr ast, 
m an y sp otty re action produ cts with the an t i-SMase an t ibo d y w e re 
o bserved in th e stra tum g ranul osum and in th e st ra tum corn e um 
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Figure 2. A 65-kDa protein is an epidermal protein of pi 5.6. T he 
homogenate o f the epidermis obtained fi·om suction blisters was separa ted 
by nonequi librium pH-gradient gel electrophoresis in the first dimension 
(hori zon ta l direction) and by SDS-PAGE in a 12.5%, ge l in the second 
dimension (ve rtical direction) . (A) Coomassic blue sta ining that shows the 
maj o r human epide rmal proteins . (B) Jmmunoblot wi th the anti-saposin D 
antibody. -> indicates the 65- kDa pro tein of pi 5.6. 
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Figure 3 . Immunoperoxidase microscopy of adult human skin labeled with anti-saposin D antibody (a,b ,c) and anti-SMase antibody (d) . T he 
innermost stratum corneum cell s were stained (a ,b,c). In <tddition. spotty reaction prod ucts were also observed in the stra tum granulosum cells by anti-SMasc 
antibody (d). (a,d) In terfo llicular epidermis. (b) Acrosyringium . (c) H air canal epithelium. (a-d) Sam e magnification. Scale bar, 50 J.Un. 
(Fig 3d) . Jmmunoreaction products were observed in the epithe-
lium of the esophagus, pneumocytes of the lungs, hepatocytes, and 
glandular cells of the stomach but not in the tongue or bladder 
epithelium (Table 1). 
Prosaposin-Like Protein Is Mainly Found in the Cytoplasm 
and on the Cell Envelope of the Stratum Corneum by Using 
Immunoelectron Microscopy As shown in Fig 4, most gold 
particles appeared to be located in the intercellular space and on the 
cell membrane at the granular-con1eocyte transition zone . A few 
gold particles were found in small vesicles as large as the lam ellar 
body, although they lacked lamellar structut·e. ln the intercorneo-
cyte domain in the stratum corneum, gold particl es were located at 
the periphery of the corneocyte plasma m embrane. The percent of 
the total number of grains in the cytoplasm, on the cell envelope, 
and in the intercellular space determin ed in five electron micro-
graphs, the magnification of which was X 5000, was 37 .26 :::':: 
12.09%, 45.36 ::+:: 13.05%, and 17.38 :::':: 9.04'Yo (mean ::+:: SD), 
respectively. 
The Amount of Prosaposin Is Significantly Decreased in 
Atopic Skin The blotted protein bands fi·om atopic skin of AD 
patients were allowed to react with either anti -saposin D antibody 
or anti-SMase antibody. The amount of the 65-kDa protein 
(prosaposin) in atopic skin was 4. 1 ::+:: 2.0 /Lg per 7 mm 2 (n = 10) , 
which was 66.1% of that in the normal control (6.2 ::+:: 1.5 f.Lg per 7 
mm2 , n = 10). In contrast, the amount of the 58-kDa protein 
(SMase) in atopic skin was 2. 9 ::+:: 0.5 f.Lg per 7 mm2 (n = 6) , which 
was similar to that in the normal control (2.8 ::!.:: 0.6 Mg per 7 mm 2 , 
n = 6) (Figs 5, 6). 
Table I. Reaction of Anti-Saposin D Antibody with 
Various Human Tissues 
T issue'' 
Esophagus 
Lung 
Liver 
Stomach 
Tongue 
Urinary bladder 
Anti-Saposit1 0 Antibody R.cactiviry1' 
+ membran e of epithelium 
+ pneumocytes 
+ hepatocytes 
+ gland ce lls 
'' T issues were obtained from normal individu :.ds by surgical operations, embedded 
in OCT compound , and kept - sooc until use . 
1
' The labeled strept-avidinc bi otin method (LSAB rncthod) was used to detect the 
antigen. 
DISC U SSION 
The anti-saposin D antibody reacted only with a 65-kDa epidermal 
protein that may be prosaposin, the precursor protein of saposin D, 
judging from its molecular weight. No 10-kDa protein reacted with 
this anti-saposin D antibody, even if 5- or 1 0-fold the amount of 
epidermal extract was subj ected to immunoblot analysis, but the 
65-kDa prote in was degraded to three proteins (32, 23, and 
15-kDa, respectively ; data not shown) when the epidermal extract 
was subjected to SDS-PAGE with 1 f.Lg of trypsin and then 
immunoblotted . On the other hand , in cubation of the extracts from 
brain, lungs, or spleen o f rats with this anti-saposin D antibody 
revealed cross-reaction with 65- and 48- kDa proteins in the brain 
extract, a 1 0-kDa protein in the lung extract, and 48- and 1 0-kDa 
pro teins in the spleen extract, which were prosaposin, trisaposin, 
and saposin D, respectively (data not shown) . T hese reaction 
Figure 4. Anti-saposin D antibody mainly labels the membrane 
and partly the cytoplasm of the innermost ceUs of the stratum 
cornelun. Almost all gold particles were loca ted on the membrane of the 
stratum corneum cells (c), and some gold particles were fo und in the 
cytoplasm of the innerm ost cell o f the stratum corneum. In the granular cell 
(g), a few gold particles were located on the m embrane of the lamella 
granule-like vesicles . Keratohyalin granule (k) are also indicated . Scale bar, 
1 J.'l11 . 
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Figure 5. A 65-kDa epidermal protein is decreased in the skin 
extracts of AD patients. Skin proteins from four normal controls (A-C) 
and AD patients (D-F) were separated by SDS-PAGE, blotted, and reacted 
with either anti-sapos in D antibody (C,F) or anti-SMase antibody (B,b/. 
Extracted proteins were stained by Coomassie brilliant blue R (A,D). 
profi les tiom the three tissues were similar to those reported 
previously (Sa no et n/, 1989; Hineno et nl, 1991 ). 
Therefore, SAPs in human epiderm1s may exist in the form of 
prosaposin, the degradation of which may be inhibited by the 
presence of an inhibitor or by the absence of a protease. Although 
it is not certain whether epidermal prosaposin can activate GCase, 
SMase, or CDase to the same extent as do saposin C and D, 
epidermal prosaposin may activate GCase, SMase, or CDase, 
beca use prosaposin in milk and semina l plasma activated /3-gluco-
sidase and SMase (Hiraiwa et nl, 1992, 1993). T here are contradic-
tory findings about the function of saposin D; saposin D, but not 
SMase, liom a Gaucher patient's spleen activated CDase in cu ltured 
fibroblasts (ill JJivo) fi·om a normal person (Klein ef n/, 1994), but 
saposin D activated SMase in ,,itro (Morimoto et nl, 1988; Tay~1ma et 
nl, 1993). 
Because there was a decrease in th e amount of ceramide (66.6'Yo 
of the normal control) in the nonlesiona l skin of AD patients 
(Imokawa et nl, 1991), we expected a decrease in production o r an 
increase in degradation of ceramides. T here are three pathways in 
ceramide production as described in the b1troduction, and a 
catabolic enzyme of ceramides, CDase, exists in pig and human 
epidermis (Wertz and Downing, 1989; Wertz and Downing, 
1990a,b; Wakita ct: a/, 1992; Stwart and Downing, 1995) and 
converts cera mides to sphingosine, which is a potent inhibitor of 
protein kinase C (Hannun et nl, 1986; Hannun and Bell, 1989). The 
activities of GCase, CDase, and SMase, however, were normal in 
atopic skin Qin el nl, 1994), and the amount of SMase was also 
normal in otu· study. Whereas the anti-SMase antibody cross-
reacted with the 70-kDa protein of human placental SMase (Sug-
awara, 1982), and the localization of the antigen of this antibody 
was identical to th e localization of SMasc activity (Menon et n/, 
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Figure 6. Prosaposin was decreased in the atopic nonlesional skin. 
Amount of prosaposin and SMase in either atopic skin (AD) or nonnal 
control skm (N) de termined by the ELISA method, obtained from the inner 
surf:1ce of th~ ~1pper ~rm. The decrease in the amount of prosaposin in AD 
skin was statJStl c,Ill y sJgmficant (p < 0.05). Only one skin sample was taken 
from one AD pat1ent or normal person . Error bnrs, SD (n = 1 0) . 
1986; data not shown), tllis antibody also reacted with an epidermal 
SMase. 
In tlus study, as the amount of prosaposin was decreased the 
activi~ies of both GCase and CDase could be suppressed. If sa;osin 
D ac~vates CDase (KJ em et nl, 1994) to the same extent that saposin 
C activates_ GCa_se, the amount of ceramides may not be changed. 
If prosap?s'_n activates GCase and SMase, however (Mm·imoto cl nl, 
1988; f-hra1wa e/ nl: 199_2; Tayama et n/, 1993), two generation 
pathways of cermmdes m the epidermis would be suppressed, 
beca use the amount of prosaposin was decreased. Furthermore the 
conv~rsion fron~ either glucosylceramide to ceramides or sphi;1go-
myelm_ to ceratmdes would be insuffi cient in atopic skin, supporting 
the ev1dence for the decrease of ceramides (Imokawa et nl, 1991). 
T he decrease of ceramides in atopic lesiona l skin may also be 
explat~ed, how~v~r , by difl:erences in the major catabolic pathways 
o~ sphmgomyebn m AD and normal epidermis. Most sphingomy-
elm_ was degraded by a spllingomyelin acylase to fi·ee £1tty acids and 
sphmgosyl-ph o~phorylcholine instead of ceramides (Murata cf nl, 
1996). The act1v1ty of this acylase, however, was much higher in 
the lesJOnaJ skin of AD, in wh.ich few lamellar granu les were 
produced. T herefore, th.is acylase may be abnormally expressed in 
numerous large lysosomal granules in the irritated kerati.nocytes 
(Prose et nl, 1965), wh.ich is not a constitutional change of AD. 
REFERENCES 
Eli ns PM, Friend OS: The pcrrncability harrier in mammalian l!pidcrmis . J Cc:/1 Bioi 
65:'1 80-J 91, 1975 
Frcinkel R.K , Tr~\zyk TN: Lipid composition ;md ncid hydro la se contcn r of lamcJiar 
grnnul cs of fecal rat epidermis. J In Pest Dcnuatol 85 :295-298. 1985 
Furst W . Sandhon· K: Activator proteins and topolo!,'Y of lysosomal sphingolipid 
catabolism. Biocilim Biopii)•S Acta 11 26: 1-16. 1992 
G ucsdon JL, Tcrnynck T, Avramcns S: The usc of avidin-b iotin interaction in 
irnmunocttzym;l t ic tcclmiqucs. j Hislocl! l.' lll C rtoclle"' 27: I 13 I -1!3Y, 1979 
Hanifin JM , R~ i ka G: Di:Jgnost"ic features of ;ltopic dcrmnticis. Artn 01'mt Veuen~ol 
S11ppl (Stocklt) 92:44 - 47 . 1980 
Hannun VA, De ll ~: Fun ctions of sphingolipids and sphingolipid breakdown 
products in cellu lar regulation. Sciwce 243:500-507. 1989 
Hannun VA, Loomis C R., Merrill A_H , Bell ltM: Sphingosint! inhibition of protein 
VOL. 109, NO. 3 SEPTEMB ER 1997 
kim\sc C <\Ctivity omd of phorbol dihutyratc binding iu 11irn) and in human phndcts. 
J Bioi C ile111 26 1:12604 -12609, 1986 
l-lineno T, Sana A, Kondoh K , Uc uo S, Kakimoro Y, Yoshida K: Secretion of 
sphingolipid hydrola se activator precursor, prosaposin. BitJcbe111 Biophys Res 
Co r111111111 176:668-674. 1991 
Hiraiw:1 M , O 'llri en J S. Kishi.rnoto Y. Gn ld zicka M , Fluharty AL, G inn s El , Martin 
BM: Isolation , characterization, and proteolysis of human prosaposin . the 
precursor of saposin (sphingolipid activator pro tein s). Arch Bi(lt hclll Bi(}p/i}'S 
304:'11 0 -11 6. 1993 
Hir11iwa M, Soed:1 S. Kishi mota Y, O'Brien JS: Binding and transport of g;m gliosi.des 
by prosapos.in . Proc N11tl Acad Sci USA 89:11 254 -11 258, 1992 
Holleran WM, Feingold IG1.., Man MQ. Gao \V N, Lee JM, Elias PM: 11..egulatiou of 
epidermal sphingolipid synth es is by permeability barrier fun cti on . J Lipid Res 
32:1'151-11 58, 1991b 
Holle ran WM . M;rn MQ, G;ro WN , Menon GK, Elias PM , Feingold KR: Sphingo-
lipids arc. required for mammalian epidermal b;'lrrlcr fun.ction. lnhibltlon of 
sphingoli pid syuth csis de lays barrier recove ry afte r acute pe rturbation . J C li11 
fr11 •est 88 :1338-:1345. 199la 
Holle ran WM . Takagi Y, Imokawa G, Jackson S. Lee JM , Elias PM: /3-glu cocercbro-
sidnse activi ty in murine epidermis: chilrncte ri z:Jtion and loc:diza tio n in rc1acion to 
diffcrcmiation. J Lipid Res 33 :1 20 1-1 209. 1992 
Holleran WM, Takagi Y. Menon GK. Legler G, Feingold KJt. Eli;rs PM: Processing o f 
cpiderrrwl glucosylccramides is rcquin~d fu r optima l m;HumaHan cutaneo us 
permeability barrier fun ctio n. J C li11 illll l'Sf 91: 1656- 1 664, 1993 
lmokawa G, Abe A, Jin K. Higak.i Y. Kawashima M. 1-Iidan o A: Decreased level of 
cc r:1midcs in stratum co rn eum of :1topic derma tit is: an etio logic f.1cro r in atopic 
dry skin ? J /IIPCS I Dnuu1U1/ 96:523-526. 1991 
Jin 1< , Higaki Y, Tak:1gi Y, Higuchi K, Yada Y, Kawashima M, lmo kaw;1 G: Analysis 
of beta-glucoccrcbJ-osidasc :.111d ccramidasc activiti es in atopic and aged dry skin. 
Arta Dcr111 Ve11crcc>f (Stocklr) 74:337- 340, 1994 
Kle in A. 1-Iensder M. Klein C , Sm.nk.i K, 1-larzer K, SandbofFK: Sphingolipid ac tivator 
pro tein I) (sap-D) stimula tes th t! lysosoma l dcgrad;1tion of ccramidc ;,, uir"'· 
Bi! l(lte~ll Biophys Res Cm11111rm 200: 1440-144 8, ·1994 
Menon GI< , Grayson S. El ias PM: Cytochemi cal and biochemical localization of lipase 
and sphingomyclinasc activity in ntammaliaJI cpidcnn is. J ltll't:SI Dcrlllaw/86:59 .1-
597, 1986 
Morimoto S. Martin DM, Kishimoto Y, O ' Brien JS: Saposin D: A sphingomyc linasc 
activnt.o.r. JJiorhe111 Bi,Jphrs U..~:s Co t/11111111 56:4 03-4 ·1 0, 1988 
Mur;.Jta Y, Ogatn J. Hi gaki Y. Kaw;lsh_i_rrw M . Yada Y, Higuchi _K, Tsuch_iyn T, 
Kawaminami S, lm ok t.lwa G: Abno nnal expression of sphingomyelin ncylmc in 
atopi c dermatitis: an etiologic f.1 ctor fo r ccnunid e dcfi cienC)'? J l utJt'S f Dcnuatol 
106: l 242-'1249, '19% 
PROSAPOS IN JN ATOPI C SKIN 323 
O 'Brien JS, Kishimoro Y : Saposin protein s: srructurc, function , and role in human 
lysosomal sro rnge di sorders. FASE/3) 5:30'1 - 308, 1991 
Prose PH . Scdlis E, Bigelow M: Th e. demonstration of lysosomes in the discnsed skin 
of iaf.1nts witii infanti.le eczema. J l1111Csf Dcrmawl 45:448 - 457. 1965 
Quintern LE, Schuchman EH. Lev ran 0, Suchi M , Fcrli.llz K. Reinke 1-1 , Sandhofr K. 
Dcsnick RJ: [so lation of eDNA clones encodin g human acid sphingom )'Ciinase: 
occurrence o f alternatively processed trauscripts. EMBO J 8:2469-2473, 1989 
Ranasinghc A W, Wertz PW. Downing DT. Mnckcnzic IC: Lip id composition of 
cohesive and desquamated corneocytcs fro m m ouse ear skiu. j llwcs1 Dl•rmmol 
86:187-1 90 , 1986 
Sau o A. Hincno T . Miz uno T , Kondoh K. Ucno S. Kakirnoto Y , lnui K: Sphjngolipid 
hydrol ase acti va tor proteins and th ei r precursors. Bioclrct/1 Bi~ph)'S Res Cm111111111 
165: l19l-11 97. 1989 
Scguchi T , C ui C Y, Kusud::1 S, Takahashi M. Aisu K. Tczuka T : Decreased expression 
of ftlaggrin in atopic skin. Ard 1 Drrnrntol Res 288:442-44(>, 1996 
Stw;lrt M E. Downing DT: Free sphingosin cs of human skin include 6-hydroxysphin-
gosinc and usuall y long- cha_in dchydrosphingosincs. J lnvest Dermaw/105:613-
6 18. '1 995 
Sugaw:tra N: Acid sphingom yelinasc of human placenta: purification . pro pertil!s, and 
125 iod ine labe lin g. J Bioc/rem 92:637- 646, 1982 
T:tyam:t M . Socdn S, Kishimo to Y , Martin BM: EffCct of saposins o n acid sphigom y-
c linase. Bir>r:lre/11 J 290:40 '1- 404. 1993 
Voller A . B<lrtlc tt A , Bidwe ll DE: Enzyme immunoassays w ith specia l reference to 
ELISA technique. ) C li11 l'al/ur/ 31: 507- 520, 1978 
\ Xfilki ta H. Nis ltimu r:1 K . T~1 kigawa M: Composd tio n of free long-chain (sphingo id) 
b:1scs in stratum corneum of normal and pathologic human skin condidons. 
J l11 r•w Dcnnatol 99:6 17-622, 1992 
Wertz P\Xl , Do wning DT: Ccra mid:1 sc activity in porcine epidermis. FEllS Leu 
268:11 0 -'11 2, 1990a 
\.Vertz P \.V, Dow11ing DT: Free sphingosincs in human epidermis. J 1111tes1 Dcrmatol 
94:15 9 -161 , 1990b 
Wertz PW, Downing DT: Free sphingosincs in po rcin e cpidennis. Biochi11r Biopltys 
Artn 1002:2 13-217, 1989 
\XIcrtz PW, Downing DT: Glycolipids in mammalian epidermi s: stru cture and function 
in the water barrier. Sciwce 2 17: 126 1- '1262. 1982 
Wertz P\V , Micthk c MC. Long SA , So·:mss J S, Downing DT: T he compositi on of the 
ceramidcs from human stratum corneum and from comedo nes. J llwest Dcrlllarol 
84:410-412. 1985 
Yama mur<J T, T~..·zuka T: C hanges iu sphingomydinasc :lctivity in h um:1n epide rmis 
during "g\ng. J Dt:l'lll•lto{ Sri 1 :79 - 84. 1990 
